At the time of writing, Rockwell Medical Inc [RMTI] stock is trading at $2.22, up 10.45%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The RMTI shares have gain 6.73% over the last week, with a monthly amount drifted -5.73%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Rockwell Medical Inc [NASDAQ: RMTI] stock has seen the most recent analyst activity on November 14, 2024, when Rodman & Renshaw initiated its Buy rating and assigned the stock a price target of $5. Previously, Piper Jaffray started tracking the stock with Overweight rating on June 24, 2019, and set its price target to $10. On May 13, 2019, H.C. Wainwright initiated with a Buy rating and assigned a price target of $11 on the stock. BofA/Merrill downgraded its rating to a Underperform. Stifel downgraded its rating to a Hold. Morgan Stanley started tracking with a Underweight rating for this stock on August 13, 2015, and assigned it a price target of $7. In a note dated January 27, 2015, Oppenheimer reiterated an Outperform rating on this stock and boosted its target price from $24 to $26.
For the past year, the stock price of Rockwell Medical Inc fluctuated between $1.16 and $5.15. Currently, Wall Street analysts expect the stock to reach $9 within the next 12 months. Rockwell Medical Inc [NASDAQ: RMTI] shares were valued at $2.22 at the most recent close of the market. An investor can expect a potential return of 305.41% based on the average RMTI price forecast.
Analyzing the RMTI fundamentals
According to Rockwell Medical Inc [NASDAQ:RMTI], the company’s sales were 98.92M for trailing twelve months, which represents an 19.12% jump. Gross Profit Margin for this corporation currently stands at 0.17% with Operating Profit Margin at 0.01%, Pretax Profit Margin comes in at -0.01%, and Net Profit Margin reading is -0.01%. To continue investigating profitability, this company’s Return on Assets is posted at -0.02, Equity is -0.05 and Total Capital is 0.01. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.3.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.11 points at the first support level, and at 1.99 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.34, and for the 2nd resistance point, it is at 2.45.
Ratios To Look Out For
It is important to note that Rockwell Medical Inc [NASDAQ:RMTI] has a current ratio of 2.41. Also, the Quick Ratio is 2.00, while the Cash Ratio stands at 0.87. Considering the valuation of this stock, the price to sales ratio is 0.73, the price to book ratio is 2.46.
Transactions by insiders
Recent insider trading involved RAVICH MARK H, Director, that happened on Nov 15 ’24 when 19991.0 shares were sold. Director, RAVICH MARK H completed a deal on Nov 15 ’24 to sell 10000.0 shares. Meanwhile, SVP, Chief Commercial Officer Chole Timothy sold 1001.0 shares on Oct 01 ’24.
